816 - Oral Once Daily Budesonide Granules Induce Clinical Remission in Lymphocytic Colitis and Improve Quality of Life: A Randomized, Double-Blind, Double-Dummy Multicenter Trial
Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Andreas Münch(Linköping University), Guenter Boehm, Ole K. Bonderup(Aarhus University), Daniela E. Aust(University Hospital Carl Gustav Carus), Juozas Kupčinskas(Lithuanian University of Health Sciences), Lars Kristian Munck(Zealand University Hospital), Tanju Nacak(Dr Falk Pharma (Germany)), Kai-Uwe Rehbehn(Städtisches Klinikum Solingen), Roland Greinwald(Dr Falk Pharma (Germany)), Peter Amerding, Emese Mihály(Semmelweis University), Fernando Fernández‐Bañares
Cited by 0
Related Papers
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
α-Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression
|Journal of Neuroscience|2000|310
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations
|United European Gastroenterology Journal|2020|219
Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
|PLoS Computational Biology|2012|216